We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A role for fulvestrant monotherapy in the first‐line treatment of ER+ metastatic breast cancer?
- Authors
Mahtani, Reshma L.
- Abstract
The article focuses on the role for fulvestrant monotherapy in the first‐line treatment of receptor–positive (ER+) metastatic breast cancer. It mentions about the combination hormonal strategies with the hope these approaches would result in longer durations of control on this treatment. It also mentions that preclinical and clinical data suggest a dose‐response effect for fulvestrant.
- Subjects
BREAST tumors; CANCER relapse; ESTROGEN receptors; HORMONES; METASTASIS; SURVIVAL; THERAPEUTICS; TREATMENT effectiveness
- Publication
Breast Journal, 2020, Vol 26, Issue 2, p109
- ISSN
1075-122X
- Publication type
Article
- DOI
10.1111/tbj.13495